Impact of a thrombolysis research trial on time to treatment for acute myocardial infarction in the emergency department

Because time to treatment in AMI is a critical factor in long-term outcome, it is important that complex trials designed to improve reperfusion therapy do not delay the time to treatment. Participation in the TIMI 5 trial did not significantly prolong our door-to-needle time. These results indicate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 1995-08, Vol.76 (5), p.396-398
Hauptverfasser:	Boisjolie, Charlene R., Sharkey, Scott W., Cannon, Christopher P., Brunette, Doug, Haugland, J.Mark, Thatcher, Jackson L., Henry, Timothy D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Cardiology. Vascular system Cardiovascular disease Clinical Trials as Topic Coronary heart disease Drug therapy Electrocardiography Emergency Service, Hospital Heart Heparin - therapeutic use Hirudin Therapy Humans Italy Medical research Medical sciences Myocardial Infarction - diagnosis Myocardial Infarction - drug therapy Streptokinase - therapeutic use Thrombolytic Therapy Time Factors United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!